SURENDRA K VERMA
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology HUTCHINSON, KS NPI 1760529697
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology KS ABBVIE INC. All categories
General Payments — all program years on this page
$1,174.29
- Category: General Payments
- Program years: PY2018–2019
- Record count: 12
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $1,017.69 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $900.00 | 1 |
| Food and Beverage | $117.69 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $900.00 | 1 |
| Janssen Biotech, Inc. | $31.15 | 2 |
| Amgen Inc. | $28.69 | 2 |
| Astellas Pharma US Inc | $15.63 | 1 |
| GENZYME CORPORATION | $15.09 | 1 |
| Heron Therapeutics, Inc. | $14.08 | 1 |
| Clovis Oncology, Inc. | $13.05 | 1 |
By program year
Records — PY2019 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 647866823 | AbbVie, Inc. | $900.00 | 10/21/2019 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 655791385 | Astellas Pharma US Inc | $15.63 | 01/30/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658768793 | Janssen Biotech, Inc. | $15.36 | 04/16/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658768815 | Janssen Biotech, Inc. | $15.79 | 05/13/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 663092263 | Amgen Inc. | $15.57 | 02/04/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 663092267 | Amgen Inc. | $13.12 | 05/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 674509895 | Heron Therapeutics, Inc. | $14.08 | 01/15/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 688688439 | Clovis Oncology, Inc. | $13.05 | 05/21/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 694309635 | GENZYME CORPORATION | $15.09 | 07/24/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.